Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

RheumPAC Announces New Donor Benefits in 2020

From the College  |  February 20, 2020

RheumPAC is excited to announce new benefits and giving levels for donors in 2020. The PAC’s success is due to the support of individual contributions, and the committee wants to reward and thank its most ardent supporters in 2020.

RheumPAC contributions enable the ACR to educate key legislators and their staff about the critical issues rheumatologists and rheumatology interprofessional team members face. Every dollar raised goes directly to the re-election campaigns of legislative leaders to help those who best understand our issues remain in Congress.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Because these contributions are so important to advancing the ACR’s legislative efforts, the RheumPAC Committee encourages everyone to step up to the next donation level this year. Log in to see your 2019 donation level, and make a donation today. Your continued support is greatly appreciated—every contribution helps in the fight to make our voice and the voices of our patients heard in Washington, D.C.

If you have trouble accessing the site or have any questions, contact Dan Redinger, manager of ACR advocacy & political affairs.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Table of RheumPAC donor benefits

 


Contributions to RheumPAC are used for political purposes and are not tax deductible for federal income tax purposes. All contributions to RheumPAC are voluntary and must be made with personal funds. You may refuse to contribute without reprisal. Any proposed contribution amounts are merely suggestions; you may choose to contribute more or less or not at all. RheumPAC will not favor or disadvantage anyone by reason of the amount contributed or the decision not to contribute. Federal law prohibits contributions from corporations. RheumPAC participants must be U.S. citizens or permanent resident aliens.

Share: 

Filed under:Legislation & Advocacy Tagged with:donationsRheumPAC

Related Articles

    November, a Busy Month for RheumPAC

    October 21, 2022

    In November, RheumPAC will be leading its annual matching campaign and hosting two events at ACR Convergence 2022. Thanks to matching donors, every contribution in November will be amplified.

    I RheumPAC, Do You?

    September 1, 2009

    For many years, the ACR board of directors and Government Affairs Committee have done exemplary work in keeping members abreast of legislative regulatory issues that affect all aspects of rheumatology, including patient and physician/healthcare professional issues, education, and research. Through advocacy, the ACR advances rheumatology and fosters excellence in the care of people with, or at risk for, arthritis and rheumatic and musculoskeletal diseases. One might say that advocacy is a cornerstone of this organization.

    Advancing the ACR’s Legislative Priorities in 2021

    January 11, 2021

    With a new Congress and many new legislators in key leadership positions, your support today will help RheumPAC start the year off strong.

    A Huge Thank You to 251 People

    March 18, 2011

    RheumPAC supporters are helping to advance rheumatology

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences